Wilmington, Massachusetts - AdvanSource Biomaterials Corp., a developer of polymer materials for medical devices, has filed a patent for its new ChronoSil silicone-urethane copolymer, the company said 5 Nov.
According to Advansource, the ChronoSil product family "maintains the inherent benefits of a polycarbonate-based urethane, including high pressure resistance, tensile-strength and superior chemical resistance combined with silicone's industry-recognised advantages such as heightened elongation, superior elasticity and a low coefficient of friction."
"We were pleased to announce our new biomaterial product, ChronoSil, a thermoplastic silicone-polycarbonate-urethane, which was exhibited at the recent Medtec Ireland Medical Design and Manufacturing Exhibition and Conference in Galway, Ireland," said Michael Adams, president of AdvanSource Biomaterials.
"Two of the objectives that are key to our business strategy include the development of innovative biomaterials to meet the needs of medical device developers and manufacturers while building additional value through a growing portfolio of patented products," he added. (RD)